Contact Us
Drug Search Results
More Filters [+]

Besifloxacin

Alternative Names: besifloxacin, bol-303224-a, isv-403, isv403, isv 403, besivance
Latest Update: 2023-10-19
Latest Update Note: Clinical Trial Update

Product Description

Besifloxacin ophthalmic is used to treat bacterial conjunctivitis (pinkeye; infection of the membrane that covers the outside of the eyeballs and the inside of the eyelids). Besifloxacin is in a class of medications called fluoroquinolones. It works by killing the bacteria that cause infection. (Sourced from: https://medlineplus.gov/druginfo/meds/a610011.html)

Mechanisms of Action: DNA Gyrase Inhibitor,TOP4 Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Ocular,Topical,Ophthalmic

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Australia | Bangladesh | Brazil | Canada | Colombia | Egypt | India | Jordan | Lebanon | Malaysia | Mexico | Singapore | South Africa | Taiwan | Thailand | Turkey | United Arab Emirates | United States | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Besifloxacin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title

04/25/2022

News Article

 Ocular Therapeutix™ to Present Pre-Clinical and Clinical Data at the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

11/16/2020

News Article

 Bausch Health Announces Investigational In Vitro Data Indicating Complete Inactivation Of SARS-CoV-2 With LUMIFY® And BESIVANCE® Eye Drops Preserved With Benzalkonium Chloride

06/15/2020

News Article

 Ocular Therapeutix™ to Present Data at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

10/07/2019

News Article

 Bausch + Lomb Announces New Scientific And Clinical Analyses To Be Presented During The American Academy Of Ophthalmology And American Academy Of Optometry Annual Meetings

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions